Cellartis Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 60

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $41.4M

Cellartis General Information

Description

Operator of a biotechnology company focused on pluripotent stem cells and technology for drug discovery research. The company provides stem cell derived products and technologies in the field of regenerative medicine. It develops human embryonic stem cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. The company was spun out of University of Gothenburg.

Contact Information

Formerly Known As
Cell Therapeutics Scandinavia
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Arvid Wallgrens Backe 20
  • 413 46 Gothenburg
  • Sweden
+46 031-758
Primary Industry
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Arvid Wallgrens Backe 20
  • 413 46 Gothenburg
  • Sweden
+46 031-758

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellartis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 04-Nov-2011 $41.4M Completed Product Development
4. Grant 18-Jan-2007 Completed Product Development
3. Early Stage VC 13-Dec-2005 Completed Product Development
2. Grant 14-Oct-2003 $1.91M Completed Product Development
1. Early Stage VC 17-Sep-2001 $1.91M $1.91M Completed Product Development
To view Cellartis’s complete valuation and funding history, request access »

Cellartis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellartis Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
A+ Science Corporation Minority
Barnwik Corporation Minority
Bio Fund Management Venture Capital Minority
Catella Holding Holding Company Minority
InnovationsKapital Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Cellartis FAQs

  • When was Cellartis founded?

    Cellartis was founded in 2001.

  • Where is Cellartis headquartered?

    Cellartis is headquartered in Gothenburg, Sweden.

  • What is the size of Cellartis?

    Cellartis has 60 total employees.

  • What industry is Cellartis in?

    Cellartis’s primary industry is Biotechnology.

  • Is Cellartis a private or public company?

    Cellartis is a Private company.

  • What is the current valuation of Cellartis?

    The current valuation of Cellartis is .

  • What is Cellartis’s current revenue?

    The current revenue for Cellartis is .

  • How much funding has Cellartis raised over time?

    Cellartis has raised $11.3M.

  • Who are Cellartis’s investors?

    A+ Science, Barnwik, Bio Fund Management, Catella Holding, and InnovationsKapital are 5 of 8 investors who have invested in Cellartis.

  • When was Cellartis acquired?

    Cellartis was acquired on 04-Nov-2011.

  • Who acquired Cellartis?

    Cellartis was acquired by Cellectis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process